Are you a new member? Sign up now
Login area
| Sign up
close
SYNFLORIX - - 1
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J07AL02 | B | Polysaccharide from each of 10 capsular types of pneumococcus (conjugated to carrier proteins) adsorbed onto aluminium phosphate - 1mcg/0.5ml, Polysaccharide of serotypes 41,2, 18C1,3 and 19F1,4 - 3mcg/0.5ml, 1 adsorbed onto aluminium phosphate - 0.5mg Al3+, 2 conjugated to protein D (derived from NTHi) carrier protein - ~ 13mcg, 3 conjugated to tetanos toxoid carrier protein - ~ 8mcg, 4 conjugated to diphteria toxoid carrier protein - ~ 5mcg | 6002 | 218767/09 | SYNFLORIX | 1 | Injectable suspension | IM | Abela Frères S.A.L. | GlaxoSmithKline Biologicals SA | Belgium | 4,675,228 L.L | 23.08 | B | GlaxoSmithKline Biologicals SA | Belgium | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024